Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
Summary
- ART should be initiated in all pregnant women with HIV regardless of CD4+ cell count or HIV-1 RNA level
- Resistance testing, CBC, and renal and liver function testing should be obtained before treatment initiation
- Appropriate OI prophylaxis should be started based on CD4+ cell count
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Initial Antiretroviral Therapy, Pregnancy, Women